 "Merck Life Science partners with Aragen to boost biotech R&D in India")
Merck Life Science has entered into a strategic partnership with Aragen, an R&D and manufacturing solutions provider in the life sciences industry. The collaboration focuses on expediting the development of monoclonal antibodies (mAbs) and other novel modalities.
The Memorandum of Understanding (MoU) was officially signed by Aditya Sharma, Head of Process Solutions for the India Region at Merck Life Science, and Subodh Deshmukh, CEO of Aragen Bioscience.
Under this MoU, Merck Life Science will supply equipment and technologies to Aragen, facilitating a more efficient clinical-to-commercial process timeline. This collaboration is expected to streamline the development of novel molecules and support scale-up efforts for emerging biotechnology startups in India.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%